1 completed, 1 withdrawn. .
Follow Ceramidase Deficiency: new trials by email Literature Review of Ceramidase Deficiency trials Research Report on Ceramidase Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biomarker for Farber Disease (BioFarber) Farber's Lipogranulomatosis, Ceramidase Deficiency | Withdrawn | CENTOGENE GmbH Rostock | 2018-08-20 | 2023-02-13 | ||
| Farber Disease Natural History Study Farber Disease, Farber's Disease | Completed | Sumitomo Pharma Switzerland GmbH | 45 | 2017-11-22 | 2020-01-18 |
Farber Lipogranulomatosis (2) · Lysosomal Storage Diseases (2) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Central Nervous System Diseases (1) · Connective Tissue Diseases (1) · Erdheim-Chester Disease (1) · Genetic Diseases, Inborn (1) · Hepatomegaly (1) · Infant, Newborn, Diseases (1) · Lipid Metabolism Disorders (1) · Lipidoses (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Lipid Metabolism, Inborn Errors (2) · Lysosomal Storage Diseases, Nervous System (2) · Nervous System Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Central Nervous System Diseases (1) · Digestive System Diseases (1) · Genetic Diseases, Inborn (1) · Hemic and Lymphatic Diseases (1) · Histiocytosis (1) · Histiocytosis, Non-Langerhans-Cell (1)
CENTOGENE GmbH Rostock (1) · Sumitomo Pharma Switzerland GmbH (1)
Egypt (2) · Germany (2) · India (2) · Argentina (1) · Canada (1) · Italy (1) · Sweden (1) · Turkey (Türkiye) (1) · United States (1)